Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 927772Erstellt: 25. Oktober 2026

L-Leucine, N-((1,1-dimethylethoxy)carbonyl)- → 6-[(4-Fluoro-phenyl)-hydroxy-methyl]-pyridine-2-carboxylic acid [(S)-3-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-butyl]-amide

https://huagongshe.com/reaction/927772

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktL-Leucine, N-((1,1-dimethylethoxy)carbonyl)-HCID 83170—
Edukt6-((4-Fluorophenyl)(hydroxy)methyl)picolinic acidHCID 71087341—
Edukt(S)-5-methyl-alpha-(2-methylpropyl)-1,2,4-oxadiazole-3-methanamine hydrochlorideHCID 71087826—
Produkt6-[(4-Fluoro-phenyl)-hydroxy-methyl]-pyridine-2-carboxylic acid [(S)-3-methyl-1-(5-methyl-[1,2,4]oxadiazol-3-yl)-butyl]-amideHCID 71105702—

Reaktionsschritte

The title compound was synthesized in analogy to Example 1, using 6-((4-fluorophenyl)(hydroxy)methyl)picolinic acid and (S)-5-methyl-α-(2-methylpropyl)-1,2,4-oxadiazole-3-methanamine hydrochloride (which was prepared from (2S)-2-[(tert-butoxycarbonyl)amino]-4-methylpentanoic acid (CAN 13139-15-6) in analogy to the procedures described in Example 38 a to e) as starting materials. MS (EI): m/e=399.2 [M+H]+.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS09290451B2
Quelldatensatzuspto-grants-2016_03
ORD IDord-1db098ee79d3457e8e5e30b18b0541a6
Quellennotizuspto-grants-2016_03